Note: Descriptions are shown in the official language in which they were submitted.
CA 02675073 2009-07-09
WO 2008/094558 PCT/US2008/001174
STABLE S-(+)-ABSCISIC ACID LIQUID AND SOLUBLE
GRANULE FORMULATIONS
FIELD OF THE INVENTION
The present invention generally relates to stable S-(+)-abscisic acid liquid
and soluble granule formulations and methods of making and using such
formulations.
BACKGROUND OF THE INVENTION
Abscisic acid is a naturally occurring plant hormone which acts primarily to
inhibit growth, maintain dormancy of buds, promote fruit maturation or
coloration,
activate the pathogen resistance response defense, induce senescence in
already-
damaged cells and their proximate neighbors, and help the plant tolerate
stressful
conditions. See Arteca, R. (1996), Plant Growth Substances: Principles and
Applications. New York: Chapman & Hall; Mauseth, J. D. (1991), Botany: An
Introduction to Plant Biology. Philadelphia: Saunders. pp. 348-415; Raven, P.
H.,
Evert, R. F., and Eichhorn, S. E. (1992), Biology of Plants. New York: Worth.
pp.
545-572.
Abscisic acid owes its name to the belief that this plant growth regulator
causes the abscission of leaves from deciduous trees in the fall. Absicin II
and
dormin are names previously used for this plant hormone. The chemistry and
physiology of abscisic acid and its analogs is described by Milborrow, Ann.
Rev.
Plant Physiol. 1974, 25, 259-307.
The naturally occurring form of abscisic acid is S-(+)-abscisic acid. It has
been reported that R-(-)-abscisic acid also has some biological activities.
See,
Zeevart J.A.D. and Creelman, R.A. (1988) Metabolism and Physiology of Abscisic
Acid, Annu.Rev. Plant Physiol. Plant Mol. Biol. 39, 439-473. The side chain of
naturally occurring abscisic acid is by definition 2-cis, -4-trans.
1
CA 02675073 2009-07-09
WO 2008/094558 PCT/US2008/001174
Abscisic acid was first defined in the early 1960s as a growth inhibitor
accumulating in abscissing cotton fruit and leaves of sycamore trees
photoperiodically induced to become dormant. See, Finkelstein RR, Rock CD
(2002), Abscisic Acid Biosynthesis and Response, The Arabidopsis Book: Vol.
45,
No. 1 pp. 1-48. Since then, abscisic acid has been shown to regulate many
aspects of
plant growth and development, including embryo maturation, seed dormancy,
germination, cell division and elongation. Although abscisic acid has
historically
been thought of as a growth inhibitor, young tissues have high abscisic acid
levels,
and abscisic acid-deficient mutant plants are severely stunted because their
ability to
reduce transpiration and establish turgor is impaired. Exogenous abscisic acid
treatment of mutants restores normal cell expansion and growth.
Abscisic acid is thought to initiate its effects on cells through binding to
receptor proteins, although their. ,identities and locations are still largely
unknown.
Activation of the putative receptor(s) causes a chain of events that results
in rapid
changes in ion channels and slower changes in the pattern of gene
transcription.
While many individual components of this chain of events have been identified,
a
complete picture has not yet been obtained.
Commercial formulations comprising abscisic acid are used in the
agricultural industry for various purposes, such as to increase crop yield, to
advance
fruit maturity and color development, to improve stress tolerance, to slow the
growth
rate, to adjust the flowering phase and for other uses. Abscisic acid has also
been
reported to possess insect inhibition qualities. See U.S. Pat. Nos. 4,434,180
and
4,209,530 to Visscher. Contents of these patents are herein incorporated by
reference. Abscisic acid in a powdered form is currently commercially
available
from Lomon Biotechnology Company, Ltd., a Chinese company, which markets it
as a substance that, among other uses, improves the yield and quality of
certain
crops.
However, one of the problems associated with industrial use of abscisic acid
formulations is relatively poor storage stability of solvent-based abscisic
acid liquid
formulations, hydroxylation inactivation of 8' and 9' methyl groups in plants
(U.S.
2
CA 02675073 2009-07-09
WO 2008/094558 PCT/US2008/001174
Pat. No. 6,004,905) and sunlight induced degradation and isomerization of
active 2-
cis, 4-trans-S-(+) abscisic acid into the inactive 2-trans, 4-trans-S-(+)-
abscisic acid
isomer. See, Kamuro Y. 1994. Plant and Chemical Regulation 29: 155-165.
On May 30, 2006, the California Department of Pesticide Regulation (DPR)
announced an air quality initiative to reduce pesticide-related emissions of
volatile
organic compounds (VOC). All pesticide formulations sold in California have to
meet <30% VOC content as estimated by thermogravimetry analysis (TGA).
U.S. Patent No. 6,984,609 to Divesetty et al. discloses water soluble granular
compositions of at least one plant growth regulator, preferably a gibberellin,
a
disaccharide and a surfactant.
Therefore, there is an unmet need in the art for stable S-(+)-abscisic acid
formulations for commercial applications as well as for the development of low-
VOC solid or liquid formulations to meet regulatory requirements.
SUMMARY OF THE INVENTION
The present invention is generally directed to stable S-(+)-abscisic acid (S-
ABA) liquid and soluble granule formulations. The stable liquid formulations
are
generally achieved by adding an effective amount of an antioxidant and an
ultraviolet absorber to S-(+)-abscisic acid.
The present invention is also generally directed to stable low VOC S-(+)-
abscisic acid (S-ABA) liquid formulations. The low VOC stable liquid
formulations
are generally achieved by adding an effective amount of an antioxidant, a
surfactant,
and a wetting agent to S-(+)-abscisic acid in a low VOC solvent system.
In a presently preferred embodiment, the formulation will include an
effective amount of an alcohol ethoxylate non-ionic surfactant.
In another presently preferred embodiment, the formulation will include an
effective amount of a dioctyl sulfosuccinate anionic surfactant or wetting
agent.
3
CA 02675073 2009-07-09
WO 2008/094558 PCT/US2008/001174
In yet another presently preferred embodiment, the formulation will include
an effective amount of an alcohol ethoxylate non-ionic surfactant, an
effective
amount of a propyl gallate antioxidant and a dioctyl sulfosuccinate anionic
surfactant or wetting agent.
Presently preferred low VOC solvent systems are based upon high boiling
point solvents such as polyethylene glycol of 400 molecular weight. However,
these
solvent systems can contain other solvents such as lower molecular weight
polyethylene glycols or an N, N- dimethyloctanamide/decanamide cosolvent.
The present invention is also directed to liquid compositions for regulating
plant growth comprising an effective amount of 2-cis, 4-trans-(S)-abscisic
acid and
effective amounts of an antioxidant and an ultraviolet absorber.
The present invention is also directed to liquid compositions comprising an
effective amount of 2-cis, 4-trans-(S)-abscisic acid in conjunction with an
effective
amount of a different plant growth regulator and effective amounts of an
antioxidant
and an ultraviolet absorber. Low VOC solvents such as polyethylene glycol (PEG
300 and 400) can be used in liquid formulations.
In a preferred embodiment, gibberellic acid (GA3), 6-benzyladenine (6-BA)
or N-(2-chloro-4-pyridinyl)-N'-phenylurea (CPPU) is the different plant growth
regulator.
The present invention is also directed to soluble granule compositions
comprising S-ABA, a lactose powder or a sucrose powder, a nonionic surfactant
and/or a hydrolyzed starch binder. In a preferred embodiment, the binder is a
maltodextrin with about 10% dextrose equivalence (Maltrin M100) and/or a
gelled
alcohol ethoxylate surfactant (Brij 98).
The present invention is also directed to a process of making soluble 2-cis, 4-
trans-(S)-abscisic acid granule compositions by a low-pressure extrusion
process.
4
CA 02675073 2009-07-09
WO 2008/094558 PCT/US2008/001174
The disclosed embodiments are simply exemplary embodiments of the
inventive concepts disclosed herein and should not be considered as limiting,
unless
the claims expressly state otherwise.
DETAILED DESCRIPTION OF THE INVENTION
The present invention relates to stable S-(+)-abscisic acid liquid and soluble
granule formulations and methods of using these formulations to improve the
storage and light stability of 2-cis, 4-trans-(S)-abscisic acid. More
specifically, the
present invention relates to methods of improving the storage stability and
the
photochemical stability of 2-cis, 4-trans-(S)-abscisic acid comprising adding
an
effective amount of at least one antioxidant and an ultraviolet (UV) absorber
to the
formulation.
Abscisic acid is an optically active 15-C weak acid with 8', 9' and 10' CH3
groups in the ring. The structural formula of abscisic acid is set forth
below:
Chig CHg CH3
~~~~OH
O CH3 COOH
The formulations of the present invention utilize the S-(+) enantiomer rather
than a racemic mixture of stereoisomers. Unless expressly stated otherwise, in
all
instances when the application refers to abscisic acid, it refers to S-(+)-
abscisic acid.
As used herein, all numerical values relating to amounts, weight percentages
and the
like, are defined as "about" or "approximately" each particular value plus or
minus
10%. For example, the phrase "greater than 0.1%" is to be understood as
encompassing values greater than 0.09%. Therefore, amounts within 10% of the
claimed values are encompassed by the scope of the claims.
As used in the present invention, the term "antioxidant" means any chemical
or biological compound or substance that inhibits oxidation.
5
CA 02675073 2009-07-09
WO 2008/094558 PCT/US2008/001174
As used in the present invention, the term "UV absorber" means any
chemical compound or substance that acts to absorb UV light in order to reduce
the
degradation and the isomerization of 2-cis, 4-trans-(S)- ABA caused by UV
radiation.
The phrase "effective amount" of an antioxidant or an ultra violet absorber
means a nontoxic but sufficient amount of antioxidant or UV absorber to
provide the
desired effect. The amount of antioxidant or ultra violet absorber that is
"effective"
will vary from composition to composition, depending on the particular
composition, the particular antioxidant or ultra violet absorber, and the
like. Thus, it
is not always possible to specify an exact "effective amount." However, an
appropriate "effective amount" in any individual case may be determined by one
of
ordinary skill in the art using routine experimentation. This amount is
generally at
least 0.1 weight % of the antioxidant and at least 0.1 weight % UV absorber
based
upon the total weight of the formulation.
Applicants discovered that adding an effective amount of at least one
antioxidant can significantly improve storage stability of 2-cis,4-trans-(S)-
abscisic
acid. Without antioxidants, S-ABA degrades over time; probably, the reason is
due
to oxidative degradation of the S-ABA molecule which has a highly conjugated
structure. Addition of antioxidants likely helps to negate this effect.
In addition, the active 2-cis,4-trans-(S)-abscisic acid tends to izomerize
into
the inactive 2-trans,4-trans-(S) isomer. Applicants have unexpectedly
discovered
that addition of an ultra violet absorber greatly slows down the
isomerization. The
slowdown was demonstrated through High Performance Liquid Chromatography
(HPLC) assays.
In one preferred embodiment, the antioxidant is t-butylhydroquinone
(TBHQ). In another preferred embodiment, the antioxidant is propyl gallate. In
another preferred embodiment, the antioxidant is clove oil. In yet another
preferred
embodiment, the antioxidant is ethoxyquin.
6
CA 02675073 2009-07-09
WO 2008/094558 PCT/US2008/001174
In one preferred embodiment, the UV absorber is benzophone-3. In another
preferred embodiment, the UV absorber is ethylhexyl methoxycinnamate.
A presently preferred composition of the present invention comprises from 1
to 50 weight % S-ABA, from 0.1 to 2.5 weight % antioxidant and from 0.1 to 10
weight % UV absorber. The compositions can also contain from 1 to 20 weight %
surfactant and will contain from 40 to 98 weight % solvent. The compositions
can
then be diluted prior to use as is well known in the art to apply an effective
amount
of S-ABA to plants being treated as is hereinafter discussed.
Liquid formulations of the present inverition can be prepared as either ready-
to-use dilutions or dilutable concentrates. According to the present
invention, an
antioxidant and an ultra violet absorber improve the storage stability and
photochemical stability of various dilutions of abscisic acid. The dilutable
concentrates can be diluted to a final application concentration or to any
intermediate dilution, without risk of precipitation of the active ingredient.
The
formulations according to the present invention are inexpensive to
manufacture,
stable under storage and shipping conditions, and are safe to handle and use.
A
person having ordinary skill in the art would be able to determine how to
prepare the
dilutions without undue experimentation.
(S)-(+)-abscisic acid has various agricultural applications. For example,
formulations of this invention may be used to improve stress tolerance of
plants,
slow the growth rate, adjust the flowering phase, treat seeds, inhibit the
growth of
stalk leaf, prevent pre-harvest fruit and flower drop, improve the quality and
color of
fruits, etc. It is beneficial and highly useful for solutions and granule
formulations of
abscisic acid to be stable for a long period of time, saving the end user's
time and
money associated with buying new solutions and/or granule formulations.
Possible
uses would include, for example, distribution and sale of solutions of
compositions
comprising (S)-(+)-abscisic acid, an antioxidant, and an UV absorber according
to
the present invention. The end user could then store the solution for a
prolonged
period of time as compared with abscisic acid compositions not containing the
claimed components. Moreover, because the UV absorber inhibits the formation
of
7
CA 02675073 2009-07-09
WO 2008/094558 PCT/US2008/001174
the inactive isomer of abscisic acid, the end user would probably be able to
use less
abscisic acid to achieve his needs since more of the abscisic acid would be in
the
active form.
In a preferred embodiment, a composition would also include an effective
amount of either an alcohol ethoxylate nonionic surfactant and/or dioctyl
sulfosuccinate anionic surfactant to solubilize benzophenone or
methoxycinnamate
and to improve wetting, spray retention and penetration of S-ABA in use
dilutions.
In a more preferred embodiment, the surfactants Tomadol which is a C, ~
alcohol ethoxylate surfactant and is available from Tomah Products Inc. of
Milton,
WI, Brij which is a C18 alcohol ethoxylate surfactant and is available from
Uniqema
of Wilimington, DE, and, Monawet which is a dioctyl -sulfosuccinate anionic
surfactant and is available from Uniqema of Wilimington, DE may be used.
In another aspect, the invention relates to stable S-ABA soluble granule
formulations prepared by a low-pressure extrusion process and containing water-
soluble lactose or sucrose diluent or filler. The low-pressure extrusion
process
usually encompasses the dry mixing of dioctyl sulfosuccinate wetting agent
with S-
ABA and lactose or sucrose powder as well as maltodextrin powder, followed by
wetting the resultant blend with a non-ionic surfactant binder solution and
mixing
the components into a homogenous paste suitable for extrusion. The moist paste
can
then be extruded into uniform pellets through a perforated screen or other
means.
In another aspect, the present invention also relates to liquid compositions
comprising an effective amount of 2-cis, 4-trans-(S)-abscisic acid and an
effective
amount of a different plant growth regulator. The mixtures of S-ABA with other
plant growth regulators can improve plant growth, crop yield, stress
tolerance, and
disease resistance, as well as promote floral bud initiation and flowering.
The following examples are intended to illustrate the present invention and to
teach one of ordinary skill in the art how to make and use the invention. They
are
not intended to limit the invention or its protection in any way.
8
CA 02675073 2009-07-09
WO 2008/094558 PCT/US2008/001174
The following abbreviations are used in the examples:
S-ABA is S-(+)-abscisic acid, a PGR;
6-BA is 6-benzyladenine, a PGR;
CPPU is N-(2-chloro-4-pyridinyl)-N-phenylurea, a PGR;
UV absorber is ultra violet absorber;
TBHQ is tertiary butylhydroquinone, an antioxidant;
Tenox PG is propyl gallate, an antioxidant;
BP-3 is benzophenone-3, a UV absorber;
Escalol 567 is benzophenone-3, a UV absorber, available from ISP Inc.;
Escalol 557 is ethylhexyl methoxycinnamate, a UV absorber, available
from ISP Inc.;
Tomadol 1-7 is C11 alcohol ethoxylate, a nonionic surfactant solubilizer,
available from Tomah Products, Inc.;
Maltrin M100 is malodextrin powder of 10% dextrose equivalence
available from Grain Processing Corp. of Muscatine, IA;
Aerosol OT-B is 85% sodium dioctyl sulfosuccinate powder;
Monawet M084R2W is 84% sodium dioctyl sulfosuccinate anionic
wetting agent in propylene glycol solvent;
Brij 97 is oleyl ether polyoxyethylene nonionic surfactant with 10 mole EO;
Brij 98 is oleyl ether polyoxyethylene nonionic surfactant with 20 mole EO;
Tween 20 is sorbitian monolaurate polyoxyethylene nonionic surfactant with
20 moles EO;
PEG 300 or 400 is polyethylene glycol with average 300 or 400 molecular
weight;
GA3 tech is a powder of 90% gibberellic acid, a plant growth regulator
(PGR);
6-BA tech is a powder of 99% 6-BA, a plant growth regulator (PGR);
CPPU tech is a powder of 98% CPPU, a plant growth regulator (PGR); and
GA4A7 tech is a powder of 90% GA4A7, a plant growth regulator (PGR).
Example 1
9
CA 02675073 2009-07-09
WO 2008/094558 PCT/US2008/001174
Stability of 1% S-ABA Propylene Glycol Formulations
Table 1
Adjuvant Form. A Form. B Form. C Form. D Form. E
0.1% No 0.1% 0.1%PG 0.1% 0.1%PG
antioxidant TBHQ Ethoxyquin
0.2% UV No No No No BP-3
absorber
Five formulations of 1% S-ABA were prepared in propylene glycol solvent
as set forth in Table 1 above.
The MT 46 accelerated storage stability test (measurement of degradation of
S-ABA at 54 C after 30 days) was performed on formulations A through C.
(Based
on CIPAC (collaborative International Pesticides Analytical Concil Limited)
handbook F : Physicol-Chemical Methods for Technical and Formulated
Pesticides.
1995. A regular storage stability test was performed test (measurement of
degradation of S-ABA at 25 C after 11 months) was performed on formulations A
through E. The results are summarized in Table 2 below.
Table 2
Amount of S-ABA as Measured by HPLC Assays (%)
Form. A Form. B Form. C Form. D Form. E
Initial 100 100 100 102 100
54 Cel./30 days 84 101 98 N/A N/A
25 Cel./11 months
2-cis, 4-trans 66 103 101 98 100
2-trans, 4-trans 1 1 No 2 No
As Table 2 demonstrates, Formulation A, which contained no antioxidant,
experienced significant degradation of S-ABA in propylene glycol solvent
during
storage at 54 C for 30 days. Without protection, Formulation A lost about 16%
after
CA 02675073 2009-07-09
WO 2008/094558 PCT/US2008/001174
30 days. In contrast, Formulation B and Formulation C, which contained
respectively a TBHQ antioxidant and a PG antioxidant, did not degrade.
Similarly, Formulation A lost another 18% during the regular 25 C stability
test, while the formulations containing antioxidants did not display any loss
at the
same storage conditions. The results suggest that the storage loss of
Formulation A
may be due to oxidative degradation of S-ABA molecule that has a highly
conjugated structure.
Example 2
Photochemical Stability of 1% S-ABA Liquid Formulations
Photochemical stability studies on five 1% S-ABA liquid formulations with
and without UV absorber and antioxidant (See Table 3) were conducted in the
greenhouse under a 1000 Watt lamp (HI-TEK Lightning). All formulations were
diluted to 50-60 ppm S-ABA with deionized water and were stored in clear glass
vials. HPLC assays were performed after 6, 25, and 48 hours exposure times to
measure 2-cis,4-trans and 2-trans,4-trans-(S)-ABA concentrations as shown in
Table
4.
11
CA 02675073 2009-07-09
WO 2008/094558 PCT/US2008/001174
Table 3
Photochemical Stability of 1% S-ABA Liquid Formulations
With and Without Antioxidant and UV Absorber
Ingredients Form. A Form. F Form. G Form. H Form. I
Weight %
S-ABA (90%) 1.11 1.11 1.11 1.11 1.11
Propylene Glycol 93.89 96.48 90.28 91.48 90.28
Propylene Carbonate N/A N/A 5.0 5.0 5.0
Tenox PG (99%) N/A 0.11 0.11 0.11 0.11
Citric Acid (Anhydrous) N/A 0.1 0.1 0.1 0.1
Escalol 567 N/A 0.2 0.4 N/A N/A
Escalol 557 N/A N/A N/A 0.2 0.4
Tomadol 1-7 5.0 2.0 3.0 2.0 3.0
Table 4
UV Isomerization and Degradation of 1% S-ABA Formulations in Water
Dilutions
S-ABA Concentration (ppm)
Formulation Initial 6 hours 25 hours (Weight
48 hours %)
Form. A
(Control)
2-cis, 4-trans 53.46 40.83 29.38 26.1 53.5
2-trans, 4-trans 0 10.54 20.51 22.64 46.5
% S-ABA loss 0 3.9 6.69 8.83
Form. F
2-cis, 4-trans 61.4 54.26 44 36.76 63.1
2-trans, 4-trans 0 6.6 16.03 21.46 36.9
% S-ABA loss 0 0.88 2.3 5.17
12
CA 02675073 2009-07-09
WO 2008/094558 PCT/US2008/001174
Form. G
2-cis, 4-trans 61.14 56.66 47.75 40.67 69.1
2-trans, 4-trans 0 4.6 12.03 18.18 30.9
% S-ABA loss 0 0 2.23 3.75
Form. H
2-cis, 4-trans 58.77 50.28 37.74 31.03 56.2
2-trans, 4-trans 0 7.96 19.08 24.22 43.8
% S-ABA loss 0 0.9 3.31 6
Form. I
2-cis, 4-trans 58.38 51.76 40.51 33.55 60.0
2-trans, 4-trans 0 6.94 16.71 22.41 40.0
% S-ABA loss 0 0 2.00 4.82
In this Example, glass vials with S-ABA formulations were kept under 1000
Watt greenhouse light at 85 F temperature. As Table 4 demonstrates, the
presence
of approximately 10 to 25 ppm of benzophenone-3 or ethylhexyl methoxycinnamate
UV absorber and 5-6 ppm of propyl gallate antioxidant in 50-60 ppm 2-cis, 4-
trans-
S-ABA solutions, resulted in a reduction of the isomerization to the 2-trans,
4-trans-
S-ABA and a reduction of the total S-ABA degradation. Formulation A reached
53.5% : 46.5% 2-cis/2-trans mixture after 48 hours exposure and showed 8.83% S-
ABA loss. In comparison, Formulation G with estimated 25 ppm of benzophenone-3
UV absorber and 6 ppm propyl gallate antioxidant exhibited 69.1 %: 30.9% 2-
cis/2-
trans mixture and 3.75% degradation after 48 hours of light exposure.
Moreover, the
increase of benzophenone-3 concentration from 0.2% in Formulation F to 0.4% in
Formulation G reduced the isomerization rate and S-ABA degradation.
Propylene carbonate solvent and Tomadol non-ionic surfactant were
included in liquid formulations to improve the solubility of water-insoluble
benzophenone-3 or ethylhexyl methoxycinnamate UV absorber in liquid
formulations or in use dilutions for S-ABA light protection. These antioxidant
and
13
CA 02675073 2009-07-09
WO 2008/094558 PCT/US2008/001174
UV absorber studies demonstrate that a stable and active S-ABA liquid product
can
be obtained by adding sufficient antioxidant and UV absorber in the
formulation.
Example 3
Development of Stable S-ABA Liquid Formulations
Table 5
Ingredients,
wei ng t% Form. Form. Form. Form. Form. Form. Form.
K L M N O P Q
S-ABA Tech
(90%) 1.12 1.12 1.12 2.22 N/A N/A N/A
S-ABA Tech
(96.2%) N/A N/A N/A N/A 5.28 5.28 2.6
Propylene Glycol
98.88 96.86 71.65 93.75 83.09 83.09 47.15
Ethyl lactate
N/A N/A 21.7 N/A N/A N/A N/A
Glycerine N/A N/A N/A N/A N/A N/A 50.0
Tenox PG N/A 0.13 0.13 0.25 0.25 N/A .25
Clove Oil N/A N/A N/A N/A N/A 0.25 N/A
Citric Acid, N/A 0.1 0.1 0.2 0.25 0.25 N/A
Anhydrous
Escalol 557 N/A N/A 0.15 N/A N/A N/A N/A
Escalol 567 N/A N/A 0.15 N/A N/A N/A N/A
Monawet
M084R2W N/A 1.79 2.50 3.58 6.05 6.05 N/A
Brij 97 N/A N/A N/A N/A 5.08 5.08 N/A
Brij 98 N/A N/A 1.5 N/A N/A N/A N/A
Tween 20 N/A N/A 1.0 N/A N/A N/A N/A
14
CA 02675073 2009-07-09
WO 2008/094558 PCT/US2008/001174
Table 6
Storage Stability in Brown PE Bottles (S-ABA concentration, weight units)
Time Form. K Form. Form. Form. Form. Form. Form.
L M N 0 P Q
Initial 0.99 1.01 0.99 2.05 5.11 5.12 2.51
2 weeks/54 C
N/A N/A N/A N/A 5.14 5.08 2.60
33 days/54 C
0.92 1.04 1.04 N/A N/A N/A N/A
Ambient/21
months 0.25 (75% 1.09 1.09 2.13 N/A N/A N/A
loss)
As Table 6 demonstrates, Formulation K without antioxidant protection
(control) showed 8% loss at accelerated conditions in a glass vial and 75%
loss in
ambient storage in brown PE bottles after 21 months. The CIPAC 54 and two or
four weeks storage tests may not be able to measure the long term shelf life
for S-
ABA liquid formulations due to oxidative degradation over time. However, they
can
predict the stability of a formulation as shown in Formulations L and M if
there is no
degradation at 54 C after 2 or 4 weeks storage.
All Tenox PG formulations demonstrated good storage stability with no S-
ABA degradation or 2-cis, 4-trans to 2-trans, 4-trans S-ABA isomerization. The
Clove oil containing 85% Eugenol antioxidant also demonstrated good protection
abilities in stabilizing S-ABA in Formulation P.
Formulation 0 containing Monawet wetting agent and Brij gel surfactant
has shown good wetting and spray retention in grape field trials. The surface
tensions in 100, 200, and 400 ppm S-ABA use dilutions are respectively, 33.0,
31.2,
and 31.0 dynes/cm. No tank-mixing adjuvant is required for Formulation O.
There
may be some solvent loss in PE bottle storage of Formulations L, M, or N after
21
CA 02675073 2009-07-09
WO 2008/094558 PCT/US2008/001174
months. These formulations demonstrated higher assay values after storage than
values in the initial assays.
16
CA 02675073 2009-07-09
WO 2008/094558 PCT/US2008/001174
Example 4
Representative Low VOC S-ABA Liquid Formulations
5% S-ABA Liquids
Ingredients, wt% Form 1 Form 2 Function
S-ABA Tech (96.2%) 5.2 5.2 Active
PEG 400 79.11 84.11 Solvent
PEG 300 10.0 Cosolvent
N,N- 5.0 Cosolvent
dimethyloctanamide/
decanamide
Tenox PG .25 .25 Antioxidant
Citric Acid .25 .25 PH control
Brij 97 4.0 4.0 Surfactant
MonawetMO84R2W 1.19 1.19 Wetting agent
TGA 2.91% 7.24%
A below 30% volatile organic compounds in pesticide formulations standard
has been proposed by the California Department of Pesticide Regulation to
reduce
pesticide-related emission (Air Quality Initiative). An estimate of volatile
emission
potential of pesticide can be measured by Thermogravimetry Analysis (TGA).
TGA: Pesticide samples are heated at 115 C in an environmentally controlled
chamber and then held isothermally until the rate of sample mass loss drops
below a
defined threshold.
Both Form 1 and Form 2 passed the <30% VOC requirement.
Example 5
The Combination of S-ABA with Other Plant Growth Reizulators (PGRs)
17
CA 02675073 2009-07-09
WO 2008/094558 PCT/US2008/001174
The pre-mixed liquid formulations of S-ABA in combination with other
plant growth regulators (PGRs), such as GA3, 6-BA, CPPU, and GA4A7 have been
developed for new uses as shown in Table 7. The joint action of two PGRs can
improve and expand the biological effectiveness and performance of S-ABA.
Table 7
The Combination of S-ABA with Other PGRs
Ingredients, weight % Form. S Form. T Form. U Form. V Form.W
S-ABA tech (90%) 1.12 N/A N/A N/A N/A
S-ABA tech (96.2%) N/A 2.64 4.16 4.68 2.64
GA3 tech (90%) 1.10 2.77 N/A N/A N/A
6-BA tech (99%) N/A N/A 1.01 N/A N/A
CPPU tech (98%) N/A N/A N/A 0.51 N/A
GA4A7 tech (90%) N/A N/A N/A N/A 2.77
Propylene Glycol 87.07 83.39 83.43 83.41 83.39
Propylene Carbonate 5.0 N/A N/A N/A N/A
Tenox PG 0.11 0.2 0.2 0.2 0.2
Citric Acid, Anhydrous 0.1 0.2 0.2 0.2 0.2
Escalol 567 0.5 N/A N/A N/A N/A
Tomadol 1-7 5.0 N/A N/A N/A N/A
Monawet M084R2W N/A 6.0 6.0 6.0 6.0
Brij 97 N/A 5.0 5.0 5.0 5.0
Storage Stability
Table 8
S-ABA/GA3 Assays
Time Form. S Form. T Form. U Form. V Form. W
initial 0.99/1.05 2.66/2.80 4.10/NA 4.64/NA N/A
54 C/2weeks N/A 2.58/2.41 4.10 4.59 N/A
Ambient temp./27 months 1.02/1.03 N/A N/A N/A N/A
18
CA 02675073 2009-07-09
WO 2008/094558 PCT/US2008/001174
Formulation S containing 1% S-ABA and 1% GA3 plus an antioxidant and a
UV absorber demonstrated excellent chemical stability for both PGRs after 27
months of storage at ambient temperature. In an accelerated test, there was
about
14% loss of GA3 in Formulation T at 54 C storage. High storage temperature
may
not be a good condition to predict GA3 shelf stability of lactone structure
(due to
acid hydrolysis at elevated temperature). The presence of GA3, 6-BA or CPPU
has
not shown adverse effect on S-ABA stability.
Example 6
Soluble Granule Formulations
10% and 20% S-ABA soluble granule formulations have been developed
with water-soluble sucrose or lactose diluent or filler by low-pressure
extrusion
process as shown in Table 9. The low-pressure extrusion process was conducted
as
follows.
Fine S-ABA 90% or 95% technical powder was blended with lactose or
sucrose powder as well as Maltrin powder in the presence of 1% Aerosol OT-B
wetting agent. The dry blend was easily wetted with Brij non-ionic surfactant
binder
solution, and then was mixed into a homogenous paste suitable for extrusion.
The
moist paste was extruded into fine and cylindrical pellets of uniform size
through a
perforated screen of 1mm diameter. The small pellets were pan- or fluid-bed
dried to
less than 1% moisture and were screened through -12/+50 mesh to obtain final
soluble granule products.
Table 9
10% and 20% S-ABA Soluble Granule Formulations
Ingredients, weight % 20% SG 10% SG Function
Form. X Form. Y
S-ABA tech (96.2%) 21.05 N/A PGR
S-ABA tech (90%) N/A 11.11 PGR
Lactose Powder 70.95 N/A Diluent
19
CA 02675073 2009-07-09
WO 2008/094558 PCT/US2008/001174
Sucrose Powder N/A 84.39 Diluent
Citric Acid 2.0 2.5 pH Control
Aerosol OT-B 1.0 1.0 Wetting agent
Water (10.0) (9.0)
Maltrin M100 4.0 N/A binder
Brij 98 1.0 1.0 binder
Table 10
Attrition Resistance and Accelerated Storage Stability
Attrition Resistance Form. X Form. Y
-80 mesh 0.14% 0.2%
Accelerated Storage Stability S-ABA assay (weight %)
Initial 21.2 10.49
54 C/2 weeks 21.2 N/A
Granular Formulations X and Y were prepared with an LCI Benchtop or
Dome Extruder. Only 8-10% of water in conjunction with Brij and binder was
required to wet powder mixtures for extrusion. Aerosol OT-B improved powder
wetting to make paste material. Maltrin and Brij were found to be strong
binders
for granulation. The binding systems are different fromValent's 40% ProGibb
Soluble Granules with PVP binder and from emamectin benzoate soluble granules
formulations with anionic sodium alkyl naphtalene sulfonate and/or N-methyl N-
oleyl taurate surfactant binders (U.S. Pat. App. No. 2002/0114821 Al).
Formulations X and Y have shown good attrition resistance (less than 1% -80
mesh
dust) in a 2 minute RoTap shaker test with 15 stainless steel balls.
Formulation X has shown good stability in the accelerated test. The soluble
granule formulation of low phytotoxicity is ideal for sensitive young or
ornamental
plant treatments. All EPA List 4 inerts may be used for S-ABA Soluble Granule
formulations and they are all qualified as organic pesticides.
Example 7
CA 02675073 2009-07-09
WO 2008/094558 PCT/US2008/001174
ABA formulation performance was evaluated in the field using table grape
coloration to assess efficacy. Treatments consisted of untreated control,
ethephon
control (industry standard ethylene-releasing agent), ABA technical (95% ABA
solubilized in ethanol), ABA liquid formulation, and ABA water-soluble granule
formulation. All treatments had 0.05% v/v Latron B-1956 surfactant included.
The
three ABA treatments (200 ppm ABA; 200 gallons/acre) and the ethephon control
(250 ppm at 200 gallons/acre) were foliar applied with a backpack sprayer at
10 to
20% color development (June 27) on Flame Seedless grapes commercially grown in
Arvin, California. The numbers of color clusters per 4 vines were assessed at
8 and
11 days after treatment.
Application of ABA technical increased the number of colored clusters more
than the ethephon control. More importantly, ABA liquid formulation and ABA
water-soluble granule formulation increased the number of colored clusters
more
than ABA technical. Thus, both formulations were more effective than ABA
technical.
Table 11
Comparison of ABA Formulations with ABA Technical for
Improved Grape Color of Flame Seedless Grapes
Number of colored clusters per 4 vines
Treatment
8 days after treatment 11 days after treatment
Untreated control 0.8 1.3
Ethephon control (250 ppm) 6.0 6.7
Technical (200 ppm ABA) 9.0 11.2
Liquid formulation (200 ABA 9.8 14.7
ppm)
Water-soluble granule 13.8 28.5
formulation (200 ppm ABA)
21
CA 02675073 2009-07-09
WO 2008/094558 PCT/US2008/001174
Example 8
ABA formulation performance was evaluated in the greenhouse using Coleus
wilting to assess efficacy. Treatments consisted of control, ABA technical
(95%
ABA solubilized in ethanol), ABA liquid formulation, and ABA water-soluble
granule formulation. Coleus plants were grown in four-inch diameter pots to
the 6
to 8 leaf stage (n = 4 plants/treatment). Water (15 mL/plant) was drench-
applied to
the control plants, and ABA (15 mL/plant; 250 ppm ABA) was drench applied to
ABA treated plants. The plants were held in a greenhouse without irrigation
until all
plants wilted to a point when they were determined to be unmarketable. The
plants
were rated daily for the extent of wilting on a scale from 1(no wilting) to 4
(complete wilting). A rating of 2.5 was the point at which a plant was
determined to
be unmarketable and the previous day was recorded as the marketable life of
that
plant in days.
Application of ABA technical delayed wilting and increased shelf life of
Coleus plants (Table 12). More importantly, ABA liquid formulation and ABA
water-soluble granule formulation increased Coleus plant shelf life more than
ABA
technical. Thus, both formulations were more effective than ABA technical.
Table 12
Comparison of ABA Formulations with ABA Technical for
Improved Drought Tolerance of Coleus Plant
Treatment Days of shelf life after treatment
Control 10
Technical (250 ppm ABA) 12
Liquid formulation (250 ABA ppm) 13
Water-soluble granule formulation 13
(250 ppm ABA)
22
